{"id":"https://openalex.org/W2331704697","doi":"https://doi.org/10.1177/0284185114556098","title":"Analysis of the changes induced by bevacizumab using a high temporal resolution DCE-MRI as prognostic factors for response to further neoadjuvant chemotherapy","display_name":"Analysis of the changes induced by bevacizumab using a high temporal resolution DCE-MRI as prognostic factors for response to further neoadjuvant chemotherapy","publication_year":2014,"publication_date":"2014-10-27","ids":{"openalex":"https://openalex.org/W2331704697","doi":"https://doi.org/10.1177/0284185114556098","mag":"2331704697","pmid":"https://pubmed.ncbi.nlm.nih.gov/25348477"},"language":"en","primary_location":{"id":"doi:10.1177/0284185114556098","doi":"https://doi.org/10.1177/0284185114556098","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0284185114556098","pdf_url":null,"source":{"id":"https://openalex.org/S160113820","display_name":"Acta Radiologica","issn_l":"0284-1851","issn":["0284-1851","1600-0455"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Radiologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079897031","display_name":"Jon Etxano","orcid":"https://orcid.org/0000-0002-0968-2859","observed_orcids":["https://orcid.org/0000-0002-0968-2859"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Jon Etxano","raw_affiliation_strings":["Department of Radiology, Cl\u00ednica Universidad de Navarra, Pamplona, Navarra, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, Cl\u00ednica Universidad de Navarra, Pamplona, Navarra, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086556256","display_name":"L. J. Pina Insausti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luis Pina Insausti","raw_affiliation_strings":["Department of Radiology, Cl\u00ednica Universidad de Navarra, Pamplona, Navarra, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, Cl\u00ednica Universidad de Navarra, Pamplona, Navarra, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108238828","display_name":"Arlette Elizalde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Arlette Elizalde","raw_affiliation_strings":["Department of Radiology, Cl\u00ednica Universidad de Navarra, Pamplona, Navarra, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, Cl\u00ednica Universidad de Navarra, Pamplona, Navarra, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000993037","display_name":"Jos\u00e9 Manuel L\u00f3pez Vega","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099858","display_name":"Marqu\u00e9s de Valdecilla University Hospital","ror":"https://ror.org/01w4yqf75","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210099858"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Manuel L\u00f3pez Vega","raw_affiliation_strings":["Department of Oncology, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Cantabria, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Cantabria, Spain","institution_ids":["https://openalex.org/I4210099858"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087383357","display_name":"Arrate Plazaola","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arrate Plazaola","raw_affiliation_strings":["Department of Oncology, Instituto Oncol\u00f3gico, San Sebasti\u00e1n, Guipuzcoa, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Instituto Oncol\u00f3gico, San Sebasti\u00e1n, Guipuzcoa, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Purificaci\u00f3n Mart\u00ednez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092871","display_name":"Hospital de Basurto","ror":"https://ror.org/00j4pze04","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210092871","https://openalex.org/I4210125364"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Purificaci\u00f3n Mart\u00ednez","raw_affiliation_strings":["Department of Oncology, Hospital de Basurto, Bilbao, Bizkaia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Hospital de Basurto, Bilbao, Bizkaia, Spain","institution_ids":["https://openalex.org/I4210092871"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5079897031"],"corresponding_institution_ids":["https://openalex.org/I4210135003"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.383,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.80220725,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"56","issue":"11","first_page":"1300","last_page":"1307"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.8190000057220459},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9089999794960022},{"id":"https://openalex.org/keywords/dynamic-contrast-enhanced-mri","display_name":"dynamic contrast-enhanced MRI","score":0.8859999775886536},{"id":"https://openalex.org/keywords/tumor-microvasculature","display_name":"tumor microvasculature","score":0.8840000033378601},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8289999961853027},{"id":"https://openalex.org/keywords/pharmacokinetic-parameters","display_name":"pharmacokinetic parameters","score":0.8560000061988831},{"id":"https://openalex.org/keywords/ktrans","display_name":"Ktrans","score":0.6869999766349792},{"id":"https://openalex.org/keywords/tumor-volume","display_name":"tumor volume","score":0.5090000033378601},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.7210000157356262},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9439197778701782},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.915958046913147},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.5620837807655334},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.5575143098831177},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5540696978569031},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.540245771408081},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5330231189727783},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5214680433273315},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.49378547072410583},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.47483569383621216},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4141320586204529},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4088814854621887},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3613680899143219},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.2784968614578247}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007090","descriptor_name":"Image Interpretation, Computer-Assisted","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/0284185114556098","doi":"https://doi.org/10.1177/0284185114556098","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0284185114556098","pdf_url":null,"source":{"id":"https://openalex.org/S160113820","display_name":"Acta Radiologica","issn_l":"0284-1851","issn":["0284-1851","1600-0455"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Radiologica","raw_type":"journal-article"},{"id":"pmid:25348477","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25348477","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta radiologica (Stockholm, Sweden : 1987)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1573363574","https://openalex.org/W1602426655","https://openalex.org/W1997995944","https://openalex.org/W2004791242","https://openalex.org/W2006816753","https://openalex.org/W2016532947","https://openalex.org/W2021777913","https://openalex.org/W2042098439","https://openalex.org/W2043299445","https://openalex.org/W2050761481","https://openalex.org/W2052086387","https://openalex.org/W2059667076","https://openalex.org/W2079205751","https://openalex.org/W2094823820","https://openalex.org/W2095704084","https://openalex.org/W2109606826","https://openalex.org/W2117188579","https://openalex.org/W2122976728","https://openalex.org/W2125671174","https://openalex.org/W2126275851","https://openalex.org/W2137225981","https://openalex.org/W2143910081","https://openalex.org/W2147608714","https://openalex.org/W2154621601","https://openalex.org/W2161962458","https://openalex.org/W2165932245","https://openalex.org/W4214540830"],"related_works":["https://openalex.org/W2316064168","https://openalex.org/W4386929581","https://openalex.org/W2202323636","https://openalex.org/W1487603533","https://openalex.org/W861069416","https://openalex.org/W2312426601","https://openalex.org/W2892149920","https://openalex.org/W3029545874","https://openalex.org/W2958332289","https://openalex.org/W1982924782"],"abstract_inverted_index":{"BACKGROUND:":[0],"Antiangiogenic":[1],"drugs":[2,18],"are":[3],"being":[4],"used":[5,233],"in":[6,36,89,101,111,116,152,161],"the":[7,43,107,117],"treatment":[8],"of":[9,16,45,69,119,122,194],"locally":[10,60],"advanced":[11,61],"breast":[12,62],"cancer.":[13],"The":[14,192],"effect":[15,193],"these":[17,46,207,228],"can":[19],"be":[20,232],"monitorized":[21],"using":[22],"high":[23],"temporal":[24],"resolution":[25],"dynamic":[26],"contrast-enhanced":[27],"magnetic":[28],"resonance":[29],"imaging":[30],"(DCE-MRI).":[31],"PURPOSE:":[32],"To":[33],"evaluate":[34],"changes":[35,47,151,208,229],"tumor":[37,109],"microvasculature":[38],"induced":[39],"by":[40,72],"bevacizumab":[41,70,76,188,195],"and":[42,77,85,94,110,133,137,158,170,173,182,201,206,224],"usefulness":[44],"predicting":[48],"response":[49,129,212,238],"to":[50,213,239],"further":[51,214,240],"neoadjuvant":[52,73,215,241],"therapy.":[53,216,242],"MATERIAL":[54],"AND":[55],"METHODS:":[56],"Seventy":[57],"patients":[58],"with":[59,66,127],"cancers":[63],"were":[64,82,124,130,140,185],"treated":[65],"one":[67],"cycle":[68],"followed":[71],"therapy,":[74],"combining":[75],"cytotoxic":[78],"chemotherapy.":[79],"Two":[80],"DCE-MRI":[81],"performed":[83],"before":[84],"after":[86,187],"bevacizumab.":[87],"Changes":[88],"tumoral":[90,153,221],"volume,":[91,222],"pharmacodynamic":[92,156],"curves,":[93,157],"pharmacokinetic":[95,159,225],"variables":[96,160],"(K(trans),":[97],"Kep,":[98],"Ve,":[99],"AUC90)":[100],"a":[102,142],"ROI":[103,113,162,174],"(ROI":[104,114],"1)":[105],"encompassing":[106],"entire":[108],"another":[112],"2)":[115],"area":[118],"higher":[120],"values":[121],"K(trans)":[123,164,176],"analyzed.":[125],"Correlations":[126],"pathological":[128],"made:":[131],"parametrical":[132],"non-parametrical":[134],"statistical":[135],"analysis":[136],"ROC":[138],"curves":[139],"used;":[141],"P":[143],"<":[144,190],"0.05":[145],"was":[146,196],"considered":[147],"significant.":[148],"RESULTS:":[149],"Significant":[150],"volume":[154],"(-4%),":[155],"1":[163],"(-45%),":[165],"Kep":[166,178],"(-38%),":[167],"Ve":[168,180],"(-11%),":[169],"AUC90":[171,183],"(-44%)":[172],"2":[175],"(-43%),":[177],"(-39%),":[179],"(-5%),":[181],"(-45%)":[184],"observed":[186],"(P":[189,203],"0.05).":[191],"not":[197,210,231],"different":[198],"between":[199],"responders":[200],"non-responders":[202],">":[204],"0.05),":[205],"could":[209,230],"predict":[211],"CONCLUSION:":[217],"Bevacizumab":[218],"induces":[219],"remarkable":[220],"pharmacodynamics,":[223],"changes.":[226],"However,":[227],"as":[234],"early":[235],"predictors":[236],"for":[237]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}